• Accendra Health reported early exchange tenders covering USD 478.3 million of 4.5% Senior Notes due 2029, about 99.9% outstanding.
• Valid tenders also covered USD 547.9 million of 6.625% Senior Notes due 2030, about 99.2% outstanding.
• Requisite consents were delivered to strip most covenants, remove some defaults, adjust merger terms in both Existing Notes indentures.
• Early settlement is expected June 15, 2026; offer expiration moved to June 23, 2026; late settlement expected June 25, 2026.
• Deal includes USD 326.25 million 9% Senior Secured First Lien Notes due 2032 sold for cash, alongside new secured notes exchanges.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Accendra Health Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260610686582) on June 10, 2026, and is solely responsible for the information contained therein.